Loading resource…

UC Irvine-MDA ALS and Neuromuscular Center
Inclusion body myositis (IBM) is a myopathy subtype that often presents with insidious onset and slow progression of muscle weakness, commonly misdiagnosed as a sign of aging in older adults. Recent advancements in diagnostic tools, such as specialized stains and biomarkers, have allowed for earlier recognition of the disease. The article discusses the pathogenesis of IBM, including mechanisms of autophagy and the role of T cells in its progression, as well as the challenges in treatment due to the lack of responsiveness to standard immunotherapy.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Traumatic Brain Injury
Same clinical topic · Neurology

Classification of the Epilepsies
Same clinical topic · Neurology

Neuroimaging Patterns of Intracranial Infections: Meningitis, Cerebritis, and Their Complications
Same clinical topic · Neurology

An update on management of subarachnoid haemorrhage
Same clinical topic · Neurology

ENCEPHALITIS
Same clinical topic · Neurology

INTRACEREBRAL HAEMORRHAGE
Same clinical topic · Neurology

INCLUSION BODY MYOSITIS
Same clinical topic · Neurology

PREVENTION OF STROKE
Same clinical topic · Neurology

MYOPATHIES IN CLINICAL CARE: A FOCUS ON TREATABLE CAUSES
Same clinical topic · Neurology